Oncology Information System Market: Transforming Cancer Care Through Technology

The global oncology information system market was valued at USD 2.43 billion in 2024 and is projected to grow to USD 2.61 billion in 2025, reaching USD 4.65 billion by 2033 at a CAGR of 7.5%. Maintaining profiles and treatment information for cancer patients used to be a tedious task, but technological advancements in Oncology Information Systems (OIS) now enable accurate recording and streamlined management of patient data, making cancer care more efficient and personalized.

📥 Download Sample

Market Growth Drivers

Increasing prevalence of cancer cases: Globally, there were 19.29 million new cancer cases in 2020, and this number is predicted to rise to 28.4 million by 2040, a 47% increase. The growing incidence of cancer is driving demand for OIS to simplify patient data management.
Rising investment by major market players: Companies are investing heavily in innovative OIS solutions. For example, the UK government plans to invest $26 billion in R&D by 2024–2025, supporting the development of advanced oncology systems.

Market Restraints

Lack of skilled IT professionals in healthcare: A shortage of qualified personnel is a major barrier, with 79% of clinical IT workers in Canada needing additional training, highlighting a gap that can slow OIS implementation.

Market Opportunities

Expansion of the healthcare IT industry: Integrated healthcare IT systems reduce inefficiencies and improve patient care. Solutions such as EMR, RIS, PACS, VNA, and treatment planning are driving OIS adoption among hospitals, clinics, and research centers.

Regional Insights

North America dominates the global market, with the US alone reporting 1,762,450 new cancer cases in 2015. The presence of advanced cancer treatment centers, government initiatives, and research funding support OIS adoption.
Europe is the second-largest market, driven by significant cancer prevalence and investments in healthcare infrastructure, including partnerships with institutions like the NHS, NICE, and the National Cancer Research Institute.
Asia Pacific is emerging rapidly, with government support and growing public awareness fueling demand for OIS.
LAMEA shows healthy growth, driven by increasing cancer cases and economic development in countries like Brazil, Argentina, and Chile.

Product & Services Analysis

The OIS market is segmented into software, patient information systems, treatment planning systems, professional services, consulting/optimization services, implementation services, and post-sale/maintenance services. Software is the highest contributor, enabling appointment management, billing, clinical workflow, and patient data management. Patient information systems are growing significantly, providing comprehensive clinical data access to authorized professionals.

Application Analysis

The medical oncology segment leads the market, with rising demand for safe and effective treatment options in India, China, and other countries. The surgical segment is also growing, as cancer treatment becomes more complex and multi-modal therapies are combined with surgery.

End-User Analysis

Hospitals and physician offices dominate the market, benefiting from government initiatives and the need to manage large volumes of patient data efficiently. Research centers are also expanding, driven by increasing clinical trials and data requirements for cancer research.

Key Players in the Oncology Information System Market

Bogardus Medical Systems Inc. (U.S.), Charm Health (Australia), Accuray Incorporated (U.S.), Siemens Healthcare (Germany), Elekta AB (Sweden), CureMD Corporation (U.S.), Cerner Corporation (U.S.), Flatiron Health Inc. (U.S.), Epic Systems Corporation (U.S.), McKesson Corporation (U.S.), Bizmatics Inc. (U.S.), RaySearch Laboratories AB (Sweden), Koninklijke Philips N.V. (Netherlands), Cordata Healthcare Innovations LLC (U.S.), Varian Medical Systems Inc. (U.S.), IMPAC Medical Systems Inc. (U.S.)

Recent Developments

• June 2021: Elekta AB partnered with Philips to develop precision oncology solutions.

• September 2021: Cordata Healthcare commercialized Cincinnati Children’s Hospital identity technology for better outcomes in children.

• November 2022: Bizmatics Inc partnered with Akeso Occupational Health to deliver end-to-end healthcare services.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/